|
Get the EBSCO Health Nursing Newsletter!
|  |
Recently Updated Topics
Terson Syndrome
Fat Embolism Syndrome in Children & Adolescents
Mallory-Weiss Syndrome
Iron Deficiency Anemia in Infants & Children
Legal Issues: Communicable Infectious Diseases
Lung Transplantation
Werner Syndrome
And much more!
|
|
|
Nursing Reference Center Peer Review
| |
|
|
|
|
Welcome!
| |
Welcome back to EBSCO Health's free evidence-based nursing newsletter. We will periodically send news on the latest evidence in nursing. Please share this with your colleagues, students, practitioners and others who would benefit from this information.
|
|
Nursing Reference Center Plus in Daily Practice
| |
Kasabach-Merritt Syndrome
Rosa is an infant patient with Kasabach-Merritt syndrome. The nurse wants to learn more about Kasabach-Merritt syndrome, so she consults Nursing Reference Center Plus, keying in Kasabach-Merritt. She retrieves the quick lesson, "Kasabach-Merritt Syndrome."
The nurse learns a great deal about Kasabach-Merritt syndrome, including signs and symptoms, treatment goals, and red flags. Based on the information in the quick lesson, the nurse monitors Rosa's vital signs, administers prescribed medications and blood transfusions, and requests referrals for specialists. She educates Rosa's parents about potential complications, and treatment risks and benefits.
Note: The above-referenced quick lesson is freely accessible to all readers of the EBSCO Health Nursing Newsletter.
|
|
Quick Overview
|
Caring for Patients with Malpuech Syndrome
Malpuech syndrome (also called Malpuech facial clefting syndrome or facial clefting syndrome, gypsy type) is a complex inherited autosomal recessive disorder manifested by a spectrum of symptoms, including cognitive and growth retardation, facial clefting, ocular dysmorphias (e.g., blepharoptosis), and urogenital anomalies. Intrauterine growth retardation (IUGR) is common among individuals with Malpuech syndrome during the prenatal stage.
Malpuech syndrome is one of a group of syndromes along with Michels, Mingarelli, and Carnevale syndromes, that result from mutations in the COLEC11 and MASP1 genes. These disorders are now collectively referred to as 3MC syndrome (also called the craniofacial-ulnar-renal syndrome). 3MC syndrome is further classified as 3MC syndrome 1 (3MC1), 2 (3MC2), or 3 (3MC3); Malpuech syndrome is now classified as 3MC3.
The COLEC11 and MASP1 genes encode proteins in the lectin complement pathway and are the first to be recognized as complement-related components responsible for inflammation, and the chemotaxis cascade in the pathogenesis of development disorders. Complications of 3MC syndrome include corneal clouding and anterior chamber defects, umbilical hernia, hearing loss, growth impairment, craniosynostosis (i.e., premature closing of skull sutures), cognitive delay, urogenital (e.g., micropenis), cardiac (e.g., atrial or ventricular septal defect), and/or skeletal anomalies. A study by Priolo et al. found psychiatric manifestations were present in a patient with Malpuech syndrome in long-term follow-up.
Diagnosis of 3MC3 can be difficult and is made with a thorough history/physical, and is based on the patient's distinctive facial features. Inclusion criteria for diagnosis are the presence of two major criteria such as cleft lip/palate and typical facial features in conjunction with two minor criteria that includes mental or growth retardation, urogenital anomalies, caudal appendage. There are no specific laboratory tests-other than genetic analysis-for the diagnosis of 3MC3. Patients with sexual infantilism and short stature require endocrinology evaluation of serum growth hormone levels. Diagnostic testing (e.g., testicular ultrasound, audiometric testing) is used to monitor for complications of 3MC3.
Treatment is supportive and individualized according to presentation and requires intervention from multiple specialties. Surgery is often required to repair the congenital malformations. Education about 3MC3's pathology and treatment should be provided to the family members. Specific statistics on the prognosis for patients with Malpuech syndrome is not provided in the medical literature.
Please log in to your Nursing Reference Center or Nursing Reference Center Plus subscription to read the quick lesson on "Malpuech Syndrome."
|
|
Evidence-Based Content Update
|
Recently, the evidence-based care sheet "Prostate Cancer: Racial/Ethnic Considerations and Healthcare Treatment Disparities" was revised following review under the Systematic Literature Surveillance Program. Finding information of value to nursing practice regarding racial/ethnic considerations and healthcare treatment disparities for prostate cancer (CaP) was among the results of a research study.
Multiple studies assessing the effectiveness of active surveillance for CaP have been performed. However, black men are underrepresented in these studies-findings are based primarily on study samples of white men.In a study of 139 men, consisting of 67 black men and 72 non-black men, investigators identified a higher disease progression rate in black men than in non-black men who chose active surveillance for low-risk CaP.
We invite you to log in to Nursing Reference Center or Nursing Reference Center Plus to read updated content as it becomes available.
|
|
|
|
|